SCHEMBL28048176

SCHEMBL28048176

O=C(O)Cc1ncc(Cl)nc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGBL2 Q5U5Z8 2/20 0.42
GABRR1 P24046 2/20 0.38
AKR1B1 P15121 1/20 0.34
GABRA1 P14867 2/20 0.34
GABRA5 P31644 2/20 0.34
GABRB2 P47870 2/20 0.34
GABRA4 P48169 2/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRE P78334 1/20 0.34
GABRA6 Q16445 1/20 0.34
GABRG1 Q8N1C3 1/20 0.34
GABRG3 Q99928 1/20 0.34
GABRQ Q9UN88 1/20 0.34
P4HTM Q9NXG6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17908109 0.84 S1PR2 (0.32) NAPRTSIRT6MAPKAPK2TDP1ALDH1A1
SCHEMBL4019648 0.83 MAPKAPK2 (0.35) AGBL2SIRT6MAPKAPK2TDP1ALDH1A1
SCHEMBL28797678 0.81 AGBL2 (0.40) AGBL2GABRR1GABRA1GABRA5GABRB2
SCHEMBL27870869 0.81 AGBL2 (0.47) AGBL2GABRR1GABRA1GABRA5GABRB2
SCHEMBL30529535 0.75 PDXK (0.35) MAPKAPK2KDM4EALDH1A1PDCD1CD274
SCHEMBL19641414 0.75 PDXK (0.35) MAPKAPK2KDM4EALDH1A1PDCD1CD274
SCHEMBL4520765 0.74 GABRR1 (0.41) AGBL2GABRR1AKR1B1GABRA1GABRA5
SCHEMBL12130919 0.73 MAPKAPK2 (0.33) MAPKAPK2ALDH1A1PDCD1CD274
SCHEMBL1349353 0.72 MAPKAPK2 (0.36) MAPKAPK2KDM4ETDP1ALDH1A1CYP3A4
SCHEMBL31373452 0.72 MAPKAPK2 (0.46) MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105164121-A Perfluorinated cyclopropyl-fused 1, 3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use thereof AMGEN INC 2015-12-16 CN disclosed